← back to search

Bruce M. Cohen

Butler Hospital · US
Area of research
Psychiatry and Mental health · Radiology, Nuclear Medicine and Imaging
Research interest
Research interests include Schizophrenia research and treatment, Bipolar Disorder and Treatment, Advanced MRI Techniques and Applications, and Neuropeptides and Animal Physiology.
h-index
81
citations
32,434
works
418
NIH funding
primary concept
Medicine
email

Recent publications

Exploring penetrance of clinically relevant variants in over 800,000 humans from the Genome Aggregation Database
Nature Communications 2025cited by 10position: middledoi
Author Correction: A genomic mutational constraint map using variation in 76,156 human genomes
Nature 2024cited by 175position: middledoi
Genotype-specific effects of elamipretide in patients with primary mitochondrial myopathy: a post hoc analysis of the MMPOWER-3 trial
Orphanet Journal of Rare Diseases 2024cited by 9position: middledoi
A genomic mutational constraint map using variation in 76,156 human genomes
Nature 2023cited by 1,273position: middledoi
Inferring compound heterozygosity from large-scale exome sequencing data
Nature Genetics 2023cited by 34position: middledoi
Rare coding variants in ten genes confer substantial risk for schizophrenia
Nature 2022cited by 863position: middledoi
The 22q11.2 region regulates presynaptic gene-products linked to schizophrenia
Nature Communications 2022cited by 59position: middledoi
Addendum: The mutational constraint spectrum quantified from variation in 141,456 humans
Nature 2021cited by 61position: middledoi
The mutational constraint spectrum quantified from variation in 141,456 humans
Nature 2020cited by 10,012position: middledoi
A structural variation reference for medical and population genetics
Nature 2020cited by 1,155position: middledoi
Personalized iPSC-Derived Dopamine Progenitor Cells for Parkinson’s Disease
New England Journal of Medicine 2020cited by 507position: middledoi
Transcript expression-aware annotation improves rare variant interpretation
Nature 2020cited by 201position: middledoi
Characterising the loss-of-function impact of 5’ untranslated region variants in 15,708 individuals
Nature Communications 2020cited by 191position: middledoi
Transcriptomic Landscape and Functional Characterization of Induced Pluripotent Stem Cell–Derived Cerebral Organoids in Schizophrenia
JAMA Psychiatry 2020cited by 155position: middledoi
Landscape of multi-nucleotide variants in 125,748 human exomes and 15,708 genomes
Nature Communications 2020cited by 143position: middledoi
The effect of LRRK2 loss-of-function variants in humans
Nature Medicine 2020cited by 109position: middledoi
Dysregulated protocadherin-pathway activity as an intrinsic defect in induced pluripotent stem cell–derived cortical interneurons from subjects with schizophrenia
Nature Neuroscience 2019cited by 121position: middledoi
Auditory steady state response deficits are associated with symptom severity and poor functioning in patients with psychotic disorder
Schizophrenia Research 2018cited by 72position: middledoi
Impaired insulin signaling in unaffected siblings and patients with first-episode psychosis
Molecular Psychiatry 2018cited by 63position: middledoi
Genetic Variants of Microtubule Actin Cross-linking Factor 1 (MACF1) Confer Risk for Parkinson’s Disease
Molecular Neurobiology 2016cited by 34position: middledoi
The Human Ortholog of Acid-Sensing Ion Channel Gene ASIC1a Is Associated With Panic Disorder and Amygdala Structure and Function
Biological Psychiatry 2014cited by 80position: lastdoi
In Vivo Evidence for Cerebral Bioenergetic Abnormalities in Schizophrenia Measured Using<sup>31</sup>P Magnetization Transfer Spectroscopy
JAMA Psychiatry 2013cited by 135position: middledoi
Brain gamma‐aminobutyric acid (<scp>GABA</scp>) abnormalities in bipolar disorder
Bipolar Disorders 2013cited by 104position: middledoi
Rapid Mood-Elevating Effects of Low Field Magnetic Stimulation in Depression
Biological Psychiatry 2013cited by 95position: lastdoi
A Placebo-Controlled Trial of Acetyl-L-Carnitine and α-Lipoic Acid in the Treatment of Bipolar Depression
Journal of Clinical Psychopharmacology 2013cited by 76position: lastdoi
Ablation of Kappa-Opioid Receptors from Brain Dopamine Neurons has Anxiolytic-Like Effects and Enhances Cocaine-Induced Plasticity
Neuropsychopharmacology 2013cited by 54position: middledoi
A longitudinal pilot proton MRS investigation of the manic and euthymic states of bipolar disorder
Translational Psychiatry 2012cited by 72position: middledoi
Coenzyme Q10 Effects on Creatine Kinase Activity and Mood in Geriatric Bipolar Depression
Journal of Geriatric Psychiatry and Neurology 2012cited by 57position: middledoi

Grants

Replacement Biological Research Laboratory Facility
NSF9415143$711,1371995–1998PIRePORTER

Frequent collaborators

Döst Öngür · Harvard University6 papers (2012–2018)Perry F. Renshaw · Huntsman (United States)4 papers (2012–2013) · 2 papers (2013–2013) · 2 papers (2013–2013)Roscoe O. Brady · Beth Israel Deaconess Medical Center2 papers (2012–2013)Fei Du · Fudan University2 papers (2012–2013)Caitlin Ravichandran · Harvard University2 papers (2012–2013)Günther Schütz · Heidelberg University1 papers (2013–2013)Stephen A. Haddad · Boston University1 papers (2014–2014) · 1 papers (2013–2013) · 1 papers (2014–2014) · 1 papers (2013–2013) · 1 papers (2018–2018)Brent P. Forester · Tufts University1 papers (2012–2012)Matcheri S. Keshavan · Harvard University1 papers (2012–2012)Qi Sheng You · Qingdao University of Technology1 papers (2016–2016) · 1 papers (2014–2014)Rakesh Karmacharya · Massachusetts Institute of Technology1 papers (2020–2020)Jeffrey S. Schweitzer · Harvard University1 papers (2020–2020)Bob S. Carter · Harvard University1 papers (2020–2020)